- Home
- HCM vs ALVO Comparison
HCM vs ALVO Comparison
Compare HCM & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- ALVO
- Stock Information
- Founded
- HCM 2000
- ALVO 2013
- Country
- HCM Hong Kong
- ALVO Luxembourg
- Employees
- HCM N/A
- ALVO N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- HCM Health Care
- ALVO Health Care
- Exchange
- HCM Nasdaq
- ALVO Nasdaq
- Market Cap
- HCM 2.5B
- ALVO 2.5B
- IPO Year
- HCM N/A
- ALVO N/A
- Fundamental
- Price
- HCM $15.92
- ALVO $8.42
- Analyst Decision
- HCM Strong Buy
- ALVO
- Analyst Count
- HCM 1
- ALVO 0
- Target Price
- HCM $28.00
- ALVO N/A
- AVG Volume (30 Days)
- HCM 44.4K
- ALVO 275.0K
- Earning Date
- HCM 08-07-2025
- ALVO 08-13-2025
- Dividend Yield
- HCM N/A
- ALVO N/A
- EPS Growth
- HCM N/A
- ALVO N/A
- EPS
- HCM 0.53
- ALVO 0.34
- Revenue
- HCM $602,197,000.00
- ALVO $587,890,000.00
- Revenue This Year
- HCM $15.00
- ALVO $36.67
- Revenue Next Year
- HCM $19.91
- ALVO $42.58
- P/E Ratio
- HCM $5.55
- ALVO $26.43
- Revenue Growth
- HCM N/A
- ALVO 413.92
- 52 Week Low
- HCM $11.51
- ALVO $7.35
- 52 Week High
- HCM $21.50
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- HCM 43.91
- ALVO 37.47
- Support Level
- HCM $14.64
- ALVO $8.31
- Resistance Level
- HCM $16.17
- ALVO $9.09
- Average True Range (ATR)
- HCM 0.50
- ALVO 0.36
- MACD
- HCM -0.31
- ALVO -0.04
- Stochastic Oscillator
- HCM 24.90
- ALVO 3.67
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.